{"protocolSection":{"identificationModule":{"nctId":"NCT06213376","orgStudyIdInfo":{"id":"2312-0370"},"organization":{"fullName":"Nevada State University","class":"OTHER"},"briefTitle":"MIT Intensive Treatment Study","officialTitle":"Intensive MIT Paired With Video Feedback for Motor Speech Disorders and Aphasia","acronym":"MITTXS"},"statusModule":{"statusVerifiedDate":"2024-01","overallStatus":"ENROLLING_BY_INVITATION","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-12-28","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2024-02","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-06","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-01-09","studyFirstSubmitQcDate":"2024-01-09","studyFirstPostDateStruct":{"date":"2024-01-19","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-01-09","lastUpdatePostDateStruct":{"date":"2024-01-19","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Andre Lindsey","investigatorTitle":"Assistant Professor of Speech Pathology","investigatorAffiliation":"Nevada State University"},"leadSponsor":{"name":"Nevada State University","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval."},"conditionsModule":{"conditions":["Stroke","Aphasia","Motor Speech"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","interventionModelDescription":"Single-subject experimental design","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE","maskingDescription":"Independent Raters will be used to examine non-standardized outcomes at benchmark time points."}},"enrollmentInfo":{"count":1,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention","type":"EXPERIMENTAL","description":"20 sessions/4 weeks:\n\nVideo Feedback:\n\nS1) Participant (P1) views recording of previous session with the clinician \\& judges whether the production is intelligible.\n\nS2) S1 \\& the clinician identifies changes in motor movements that are influencing performance.\n\nS3+S4) S1+S2 \\& given support from the clinician, P1 identifies techniques improving intelligibility \\& modifies behavior accordingly.\n\nMIT:\n\nHumming - Clinician introduces the target phrase by showing a visual cue, humming the phrase, then intoning (singing) the phrase while P1 taps left-hand.\n\nUnison intoning - Clinician and P1 intone (sing) \\& tap the target phrase together.\n\nUnison intoning with fading - Clinician \\& P1 begin to intone (sing) \\& tap the target phrase together. The clinician fades out, while P1 continues to sing the rest of the phrase accompanied by tapping.\n\nImmediate repetition response to probe question - Following P1's successful repetition, the clinician intones a question and P1 intones the target.","interventionNames":["Behavioral: Melodic Intonation Therapy","Behavioral: Video Feedback Performance Review"]}],"interventions":[{"type":"BEHAVIORAL","name":"Melodic Intonation Therapy","description":"Melodic Intonation Therapy uses intonation and melody to aid individuals with aphasia with producing words.","armGroupLabels":["Intervention"]},{"type":"BEHAVIORAL","name":"Video Feedback Performance Review","description":"Participant will view recording to judge correct and incorrect productions of trained words and to identify motor techniques increasing intelligibility","armGroupLabels":["Intervention"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Intelligibility","description":"Intelligibility as measured by percentage of consonants correct and by targets produced on trained and untrained stimuli. 20 trained and 20 untrained speech phrases that are relevant to the client (measured during reading and repetition tasks)","timeFrame":"From enrollment to 4 weeks post treatment"}],"secondaryOutcomes":[{"measure":"Apraxia Battery for Adults","description":"A test to measure the presence and severity of apraxia in adults","timeFrame":"Baseline and one week following the end of treatment"},{"measure":"Assessment of Intelligibility of Dysarthria Speech","description":"A tool for quantifying single-word intelligibility, sentence intelligibility, and speaking rate of adult speakers with dysarthria","timeFrame":"Baseline and one week following the end of treatment"},{"measure":"Longer Connected Speech Assessment","description":"Change in Performance on Rainbow Passage- A public domain paragraph frequently used by speech-language pathologists to gather a speech sample of all phonemes for American English","timeFrame":"Baseline and one and four weeks following the end of treatment"},{"measure":"Quality of Life with Dysarthria (QOLdys)","description":"A reliable and valid tool to assess quality of life for patients with dysarthria.","timeFrame":"Baseline and four weeks following treatments."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Fluent English speakers\n* Sustained a left-hemisphere stroke\n* Presents with language and motor speech impairments\n\nExclusion Criteria:\n\n* â€¢ History of learning disability prior to accident (per patient report)\n\n  * Uncorrected auditory or visual impairments\n  * Not meeting the criteria of stroke\n  * Failure to provide evidence of stroke diagnosis (medical record history)\n  * History of psychiatric disorder","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Andre Lindsey, PhD","affiliation":"Nevada State University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Nevada State University","city":"Henderson","state":"Nevada","zip":"89002","country":"United States","geoPoint":{"lat":36.0397,"lon":-114.98194}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001037","term":"Aphasia"}],"ancestors":[{"id":"D000013064","term":"Speech Disorders"},{"id":"D000007806","term":"Language Disorders"},{"id":"D000003147","term":"Communication Disorders"},{"id":"D000019954","term":"Neurobehavioral Manifestations"},{"id":"D000009461","term":"Neurologic Manifestations"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4042","name":"Aphasia","asFound":"Aphasia","relevance":"HIGH"},{"id":"M15554","name":"Speech Disorders","relevance":"LOW"},{"id":"M10513","name":"Language Disorders","relevance":"LOW"},{"id":"M6064","name":"Communication Disorders","relevance":"LOW"},{"id":"M21516","name":"Neurobehavioral Manifestations","relevance":"LOW"},{"id":"M12094","name":"Neurologic Manifestations","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M7682","name":"Epinephrine","relevance":"LOW"},{"id":"M30061","name":"Racepinephrine","relevance":"LOW"},{"id":"M211010","name":"Epinephryl borate","relevance":"LOW"}],"browseBranches":[{"abbrev":"VaCoAg","name":"Vasoconstrictor Agents"},{"abbrev":"Resp","name":"Respiratory System Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}